PTI Proteostasis Therapeutics, Inc.

4.79
+0.50  (12%)
Previous Close 4.29
Open 4.34
Price To book 1.60
Market Cap 119.95M
Shares 25,041,000
Volume 341,144
Short Ratio 4.55
Av. Daily Volume 205,955

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 preliminary data from multiple ascending dose (MAD) cohorts due by the end of June 2017.
PTI-428
Cystic fibrosis

Latest News

  1. Proteostasis Therapeutics Files Investigational New Drug Application for PTI-808, Cystic Fibrosis Potentiator
  2. Proteostasis Therapeutics Announces Clinical and Regulatory Progress Across Pipeline Programs
  3. ETFs with exposure to Proteostasis Therapeutics, Inc. : June 5, 2017
  4. Proteostasis Therapeutics, Inc. :PTI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
  5. ETFs with exposure to Proteostasis Therapeutics, Inc. : May 15, 2017
  6. ETFs with exposure to Proteostasis Therapeutics, Inc. : April 20, 2017
  7. Proteostasis Therapeutics, Inc. :PTI-US: Earnings Analysis: Q4, 2016 By the Numbers : April 7, 2017
  8. Proteostasis reports 4Q loss
  9. Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update
  10. Proteostasis Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : PTI-US : March 6, 2017
  11. Proteostasis Therapeutics, Inc. – Value Analysis (NASDAQ:PTI) : January 27, 2017
  12. Proteostasis Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : PTI-US : January 26, 2017
  13. This Boston law firm won the most IPO work locally in 2016
  14. Is Proteostasis Therapeutics Inc (PTI) a Good Stock to Buy?
  15. Insiders Sell Mastercard, Facebook
  16. Proteostasis Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : PTI-US : October 17, 2016